№7 (360) / 2018

A.V. Novik
PRINCIPLES OF MODERN IMMUNOTHERAPY 		10-18
T.Yu. Semiglazova (1, 2), I.V. Berlev (1, 2), E.A. Ulrikh (1, 3), V.V. Semiglazov (1, 3), A.E. Protasova (2, 4), N.A. Brish (1), E.A. Korobeynikova (1), Yu.V. Alekseeva (1), L.V. Filatova (1, 2), A.I. Semenova (1), D.Kh. Latipova (1), G.M. Teletaeva (1), E.V. Tkachenko (1), V.V. Klimenko (1), G.A. Dashyan (1), S.A. Protsenko (1), R.M. Paltuev (1), A.F. Urmancheeva (1, 2), P.V. Krivorotko (1, 2), V.F. Semiglazov (1, 2)
GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER 		19-25
L.V. Filatova (1, 2), M.S. Motalkina (1), E.V. Kharchenko (1), I.V. Ishmatova (1), I.S. Zyuzgin (1), P.S. Shilo (1), Yu.A. Oleinik (1), Yu.A. Chudinovskikh (1), T.Yu. Semiglazova (1, 2)
TREATMENT OF RELAPSES AND RESISTANT FORMS OF HODGKIN’S LYMPHOMA 		26-32
A.D. Darenskaya, N.V. Dobrova, E.V. Stepanova
INTERCELLULAR ADHESION MOLECULES (E-CADHERIN, β-CATENIN) IN COLORECTAL CANCER: CHARACTERISTICS; ROLE IN MECHANISMS OF TUMOR INVASION, METASTASIS AND REGULATION OF TUMOR PROGRESSION; INFLUENCE ON PROGNOSIS (LITERATURE REVIEW) 		33-39
N.V. Zhukova (1), R.V. Orlova (1, 2), N.Yu. Antimonik (1), S.I. Kutukova (1, 3), N.P. Belyak (1), N.V. Popova (1)
EXPERIENCE OF TREATMENT with ANTI-PD-1: FROM WORLD STANDARDS TO REAL CLINICAL PRACTICE (CLINICAL OBSERVATION) 		40-44
D.D. Sakaeva, A.I. Iskhakova, R.I. Kunafina
CYCLIN-DEPENDENT KINASE INHIBITORS - NEW THERAPEUTIC OPTION FOR PATIENTS WITH HORMONE-DEPENDENT HER2-NEGATIVE BREAST CANCER: CLINICAL EXPERIENCE 		45-49
S.I. Kutukova (1, 2)
MODERN APPROACHES TO THE CHOICE OF THERAPY OF LOCALLY ADVANCED AND RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA: WHAT IS THE BASIS FOR THE CHOICE OF THERAPY IN CLINICAL PRACTICE? 		50-56
T.V. Gorodnova (1), A.P. Sokolenko (1), A.O. Ivantsov (1), Kh.B. Kotiv (1), M.G. Yakovleva (1), O.N. Mikheeva (2), G.I. Mikhaylyuk (2), A.S. Lisyanskaya (3, 4), K.D. Guseinov (1), E.A. Nekrasova (1), O.A. Smirnova (1), A.A. Sidoruk (1), N.E. Bondarev (1), N.S. Matveeva (1), I.E. Meshkova (1), N.A. Mikaya (1), S.V. Petrik (1), G.M. Manikhas (3, 4), S.A. Protsenko (1), I.V. Berlev (1), A.M. Belyaev (1), E.N. Imyanitov (1)
SYSTEMIC THERAPY FOR ADVANCED OVARIAN CANCER IN BRCA1 MUTATION CARRIERS – NEW THERAPEUTIC APPROACHES: RESULTS OF A PROSPECTIVE NON-RANDOMIZED MULTI-CENTER STUDY 		57-63
E.M. Slonimskaya (1, 2), P.V. Kazantseva (1), N.V. Litviakov (1, 3), M.M. Tsyganov (1), M.K. Ibragimova (1, 3), A.V. Doroshenko (1), R.U. Vernadsky (1), M.A. Vostrikova (2), N.A. Lushnikova (2)
EXPERIENCE OF PERSONALIZED APPOINTMENT OF NEOADJUVANT CHEMOTHERAPY FOR PATIENT WITH BREAST CANCER: A PROSPECTIVE STUDY 		64-70
P.I. Shabalkin
ANALYSIS OF INFLUENCE ON THE BUDGET OF THE RUSSIAN FEDERATION OF THE USE OF ORAL VINORELBINE FOR THE TREATMENT OF METASTATIC BREAST CANCER 		71-75
L.Yu. Vladimirova, N.A. Abramova, A.A. Lyanova, A.E. Storozhakova, I.L. Popova, N.M. Tikhanovskaya, K.A. Novoselova, L.A. Ryadinskaya, M.O. Ezhova, E.A. Dzhenkova
DENOSUMAB IN TREATMENT OF BONE METASTASES FROM SOLID TUMORS 		76-81
V.M. Moiseenko (1), F.V. Moiseenko (1, 2, 3), N.M. Volkov (1), G.A. Yanus (2), E.Sh. Kuligina (2), A.P. Sokolenko (2), S.N. Aleksakhina (2), V.A. Chubenko (1), K.S. Kozyreva (2), N.Kh. Abduloeva (1), M.M. Kramchaninov (1), A.S. Zhuravlev (1), V.A. Khinshtein (1), K.V. Shelekhova (1), A.A. Kudryavtsev (1), A.V. Myslik (1), A.O. Ivantsov (2), A.R. Venina (2), E.V. Preobrazhenskaya (2, 4), N.V. Mityushkina (2), A.G. Ievleva (2, 4), E.N. Imyanitov (2, 4)
Prospective II phase study on the evaluation of the efficacy of monotherapy with cetuximab as the first-line treatment for patients with metastatic colorectal cancer with wild-type KRas, NRas, and BRAF genes 		82-88
A.D. Darenskaya, N.V. Dobrova, D.A. Khochenkov, E.V. Stepanova
PROGNOSTIC SIGNIFICANCE OF THE E-CADHERIN EXPRESSION LEVEL IN PRIMARY TUMORS OF THE COLON IN PATIENTS WITH METASTATIC COLORECTAL CANCER, RECEIVED NEW CHEMOTHERAPY REGIMEN BASED ON TRIPLE COMBINATION: IRINOTECAN+OXALIPLATIN+CONTINUOUS-INFUSION 5-FLUOROURACIL AS A FIRST-LINE TREATMENT 		89-96
V.S. Fomin
POSTOPERATIVE ADYNAMIC ILEUS: PREVENTION AND TREATMENT 		97-101
T.A. Titova, N.S. Besova, V.A. Gorbunova, A.A. Fedenko, O.A. Malikhova
RAMUCIRUMAB IN A COMBINATION WITH IRINOTECAN-BASED TWO-COMPONENT THERAPY REGIMEN AS THE SECOND LINE FOR THE TREATMENT OF DISSEMINATED GASTRIC CANCER. CASE REPORT 		102-104
G.A. Khakimov (1), Kh.I. Dzhumaniezov (1), Sh.Sh. Kadyrov (1), Sh.V. Ziyaev (1), G.G. Khakimova (2)
SUCCESSFUL TREATMENT OF THE COMPLICATED FORM OF NON-HODGKIN’S LYMPHOMA OF THE CECUM. CASE REPORT 		105-111

Бионика Медиа